Evaluation of the Effectiveness of Health Literacy Education Given to Women by Teach-Back Method

Istanbul University - Cerrahpasa

Status: Begins enrollment in 1 month

Conditions: Teach Back; Health Literacy

Treatments: Other: Control Group; Other: teach-back

Study type: Interventional

Funder types: Other

Identifiers

NCT07320079

2025-708

Details and patient eligibility

About

This study aims to enhance women's health literacy levels and to examine the effectiveness of the teach-back teaching technique in improving women's health literacy. The research was designed as a randomized controlled study. In addition, this study aims to answer the question of whether health literacy education delivered using the teach-back method is effective in improving women's health literacy levels. Within the scope of the study, participants in the experimental group will receive health literacy education using the teach-back technique, while the control group will receive standard care. Data will be collected using a questionnaire method.

Full description

This study aims to enhance women's health literacy levels and to examine the effectiveness of the teach-back teaching technique in improving women's health literacy. Women aged between 18 and 65 years with a General Health Questionnaire-12 score below 4 will be included in the study. To determine the participants' socio-demographic and health characteristics, the "Personal Information Form" will be used; to assess general health, the "General Health Questionnaire-12" will be applied; to measure health literacy levels, the "Türkiye Health Literacy Scale-32 (TSOY-32)" will be utilized; and to assess self-efficacy, the "General Self-Efficacy Scale" will be employed. Additionally, the "Training Effectiveness Evaluation Form" will be used to evaluate the effectiveness of the education provided to the experimental group. The study will consist of a total of 74 participants, with 37 in the experimental group and 37 in the control group. Verbal and written consent will be obtained from participants who agree to take part in the study, and the participants will be assigned to groups accordingly. The experimental group will receive face-to-face health literacy education using the teach-back method in six sessions, each lasting 45 minutes per week. The control group will receive standard care.

Enrollment: 74 estimated patients

Sex: Female

Ages: 18 to 65 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Women aged between 18 and 65 years
• Those with a General Health Questionnaire-12 score below 4

Exclusion criteria

• Illiterate women
• Male individuals
• Those with communication difficulties
• Healthcare professionals (physicians, midwives, nurses, etc.)
• Emergency patients

Trial design

Primary purpose: Other

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

74 participants in 2 patient groups

Teach-back

Experimental group

Description:

The experimental group will receive face-to-face health literacy education using the teach-back method in six sessions, each lasting 45 minutes per week. The training will be provided by the researcher on a one-to-one basis. Health literacy education will be delivered using the teach-back method. After each session, participants will be asked to repeat what they have learned in their own words. The researcher will assess how well the participants have understood the topic. Any misunderstandings will be identified and corrected. During this process, participants will also have the opportunity to ask questions. Additional information will be provided if necessary until participants can accurately repeat the expected knowledge. The module will be considered complete once the participants have correctly expressed the information and understood the topic. The following week, the next module will begin, and this process will continue until all six modules are completed.

Treatment:

Other: teach-back

Control Group

Other group

Description:

The control group will receive standard care.

Treatment:

Other: Control Group